UGE:NYE-ProShares Ultra Consumer Goods

ETF | Drug Manufacturers | NYE

Last Closing Price

USD 47.98


-0.01 (-0.02)%

Market Cap

USD 7.77M



Average Target Price

Average Analyst Rating


STA Verdict



The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Consumer GoodsSM Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index seeks to measure the stock performance of certain U.S. companies in the consumer goods sector of the U.S. equity market. The fund is non-diversified.

Inception Date: 30/01/2007

Primary Benchmark: DJ US Consumer Goods TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.65%

Management Expense Ratio: 0.95 %

Market Stats

Unadjusted Closing Price

Adjusted Closing Price



Top Sectors


Top Regions


Valuation Growth & Performance

Share Volume

Relative Performance (Total Returns)

Relative Returns (From:    To: 2019-10-22 )

Largest Industry Peers for Drug Manufacturers

Symbol Name Mer Price(Change) Market Cap
SSO ProShares Ultra S&P500 0.90 %

-0.97 (-0.74%)

USD 2.40B
QLD ProShares Ultra QQQ 0.95 %

-1.62 (-1.60%)

USD 1.90B
UYG ProShares Ultra Financials 0.95 %

-0.66 (-1.37%)

USD 0.80B
PSQ ProShares Short QQQ 0.95 %

+0.21 (+0.78%)

USD 0.50B
DDM ProShares Ultra Dow30 0.95 %

-0.12 (-0.24%)

USD 0.36B
DOG ProShares Short Dow30 0.95 %

+0.07 (+0.13%)

USD 0.22B
UWM ProShares Ultra Russell2000 0.95 %

+0.04 (+0.06%)

USD 0.17B
DXD ProShares UltraShort Dow30 0.95 %

+0.06 (+0.23%)

USD 0.16B
MVV ProShares Ultra MidCap400 0.95 %

-0.03 (-0.07%)

USD 0.14B
URE ProShares Ultra Real Estate 0.95 %

-0.70 (-0.77%)

USD 0.14B

ETFs Containing UGE

Symbol Name Weight Mer Price(Change) Market Cap


Market Performance

  Market Performance vs.
Industry/Classification (Drug Manufacturers)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Capital Gain 41.10% 84% B 91% A-
Dividend Return 1.02% 76% C 21% F
Total Return 42.12% 84% B 90% A-
Trailing 12 Months  
Capital Gain 21.26% 82% B- 85% B
Dividend Return 1.18% 44% F 20% F
Total Return 22.44% 82% B- 83% B
Trailing 5 Years  
Capital Gain 67.99% 71% C- 84% B
Dividend Return 5.17% 63% D 17% F
Total Return 73.15% 71% C- 81% B-
Average Annual (5 Year Horizon)  
Capital Gain 8.02% 63% D 75% C
Dividend Return 0.73% 53% F 17% F
Total Return 8.75% 63% D 70% C-
Risk Return Profile  
Volatility (Standard Deviation) 17.36% 47% F 45% F
Risk Adjusted Return 50.42% 63% D 61% D-
Market Capitalization 7.77M 32% F 6% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.